- Home
- IVDA vs LGVN Comparison
IVDA vs LGVN Comparison
Compare IVDA & LGVN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- IVDA
- LGVN
- Stock Information
- Founded
- IVDA 2003
- LGVN 2014
- Country
- IVDA United States
- LGVN United States
- Employees
- IVDA N/A
- LGVN N/A
- Industry
- IVDA Computer Software: Prepackaged Software
- LGVN Medicinal Chemicals and Botanical Products
- Sector
- IVDA Technology
- LGVN Health Care
- Exchange
- IVDA Nasdaq
- LGVN Nasdaq
- Market Cap
- IVDA 3.5M
- LGVN 30.0M
- IPO Year
- IVDA N/A
- LGVN 2021
- Fundamental
- Price
- IVDA $1.64
- LGVN $2.05
- Analyst Decision
- IVDA
- LGVN Strong Buy
- Analyst Count
- IVDA 0
- LGVN 2
- Target Price
- IVDA N/A
- LGVN $8.00
- AVG Volume (30 Days)
- IVDA 40.0K
- LGVN 393.9K
- Earning Date
- IVDA 11-20-2024
- LGVN 11-08-2024
- Dividend Yield
- IVDA N/A
- LGVN N/A
- EPS Growth
- IVDA N/A
- LGVN N/A
- EPS
- IVDA N/A
- LGVN N/A
- Revenue
- IVDA $3,779,754.00
- LGVN $1,229,000.00
- Revenue This Year
- IVDA $23.76
- LGVN $161.78
- Revenue Next Year
- IVDA $229.89
- LGVN $8.62
- P/E Ratio
- IVDA N/A
- LGVN N/A
- Revenue Growth
- IVDA N/A
- LGVN 39.34
- 52 Week Low
- IVDA $1.40
- LGVN $0.77
- 52 Week High
- IVDA $10.16
- LGVN $23.90
- Technical
- Relative Strength Index (RSI)
- IVDA 41.96
- LGVN 52.20
- Support Level
- IVDA $1.40
- LGVN $1.76
- Resistance Level
- IVDA $1.72
- LGVN $2.26
- Average True Range (ATR)
- IVDA 0.10
- LGVN 0.12
- MACD
- IVDA 0.06
- LGVN 0.05
- Stochastic Oscillator
- IVDA 75.00
- LGVN 58.00
About IVDA Iveda Solutions Inc.
Iveda Solutions Inc is engaged in offering real-time IP video surveillance technologies. The company provides IoT sensors and devices for various applications such as energy management, smart homes, smart buildings, smart communities, and patients and eldercare. Its IvedaAI provides AI functions to IP cameras and network video recorders and video management systems. The group has a business presence in the U.S. and the Republic of China (Taiwan), from which key revenue is derived from the Republic of China (Taiwan).
About LGVN Longeveron Inc.
Longeveron Inc is a clinical-stage biotechnology company developing regenerative medicines to address unmet medical needs for specific aging-related and life-threatening conditions. Its investigational product is Lomecel-B an stem cell formulation sourced from the bone marrow of young, healthy adult donors and has potential mechanisms of action that can promote tissue repair and healing. The company currently has three pipeline indications: Hypoplastic Left Heart Syndrome (HLHS), Alzheimer's disease (AD) and Aging-related Frailty.